Drugs / DWP10292
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02622685 | May 2015 → Feb 2016 | — | Daewoong Pharmaceutical Co. LTD. | Completed | No outcome recorded |
| Phase 1 | NCT01423526 | Aug 2011 → Feb 2012 | — | Daewoong Pharmaceutical Co. LTD. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DWP10292 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01423526 ↗ |
| Route | Oral | “oral administration” NCT01423526 ↗ |